p53 deletion or mutation affects the number of immune cells, such as bone marrow, tumor-associated macrophages, Tregs, and TH cells, which in turn exacerbate the pro-oncogenic transformations of inflammation [107]. The gene discussed is TP53; the disease is neoplasm.